Re: BIRD FLU stocks ** LIST THEM HERE **
I belive these Financial Institutions did not buy at 4.30 just to loose the money! That's re-assuring enough for me.
Dow Jones News Services
(Copyright © 2005 Dow Jones & Company, Inc.)
NEW YORK (Dow Jones)--Novavax Inc.'s (NVAX) avian flu-vaccine strategy is in line with President George W. Bush's plans to prevent a potential pandemic, Chief Executive Rahul Singhvi said in an interview on CNBC Wednesday.
"Our strategy is very much aligned with what the president has outlined," Singhvi said. "The way our technology works is we work with genes, we take the important genes out of the flu virus and clone them...They are completely safe, they are incapable of replicating in the body."
He said the company's technology allows it to work with the most emergent strain of the virus.
Early Wednesday, Novavax entered into definitive agreements to raise $18 million through the issuance of 4.18 million shares of its stock at a price of $4.30 per share.
He said that money will be funneled into avian flu-vaccine development.
-By Cynthia Koons, Dow Jones Newswires; 201-938-2007; firstname.lastname@example.org
(END) Dow Jones Newswires